Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Surgical Oncology
|
April 1, 1997
Malignant pericardial effusion in breast cancer: terminal event or treatable complication?
E Swanepoel, J P Apffelstaedt
Folia Morphologica
|
February 16, 2017
Superficial brachial artery: a possible cause for idiopathic median nerve entrapment neuropathy
P Nkomozepi, N Xhakaza, E Swanepoel
Injury
|
September 1, 1994
Tamponade of vertebral artery bleeding by Foley's catheter balloon
J Bendahan, E Swanepoel, R Müller
Journal of Palliative Medicine
|
February 14, 2025
Does Having an Individualized End-of-Life Care Record Actually Make a Difference?
Gabriella E Swanepoel, Sophie Williams, Daniel Monnery
Die Pharmazie
|
September 12, 2003
Differences between USP and BP dissolution results for oxytetracycline capsules after accelerated stability testing
E Swanepoel, W Liebenberg, M M de Villiers
Die Pharmazie
|
March 19, 2003
Developing a discriminating dissolution test for three mebendazole polymorphs based on solubility differences
E Swanepoel, W Liebenberg, B Devarakonda, et al.
Journal of Chromatography. A
|
April 5, 1996
Fluorimetric method of analysis for D-norpseudoephedrine hydrochloride, glycine and L-glutamic acid by reversed-phase high-performance liquid chromatography
E Swanepoel, M M de Villiers, J L du Preez
Clinical Chemistry
|
June 1, 1977
Increased concentrations of serum free fatty acids falsely increase serum thyroxine as determined by competitive protein-binding
P R Pannall, E Swanepoel, J M Bennett, et al.
Drug Development and Industrial Pharmacy
|
October 12, 2000
Dissolution properties of piroxicam powders and capsules as a function of particle size and the agglomeration of powders
E Swanepoel, W Liebenberg, M M de Villiers, et al.
Drug Development and Industrial Pharmacy
|
October 13, 1999
The effect of polymorphism on powder compaction and dissolution properties of chemically equivalent oxytetracycline hydrochloride powders
W Liebenberg, M M de Villiers, D E Wurster, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Surgical Oncology
|
April 1, 1997
Malignant pericardial effusion in breast cancer: terminal event or treatable complication?
E Swanepoel, J P Apffelstaedt
Folia Morphologica
|
February 16, 2017
Superficial brachial artery: a possible cause for idiopathic median nerve entrapment neuropathy
P Nkomozepi, N Xhakaza, E Swanepoel
Injury
|
September 1, 1994
Tamponade of vertebral artery bleeding by Foley's catheter balloon
J Bendahan, E Swanepoel, R Müller
Journal of Palliative Medicine
|
February 14, 2025
Does Having an Individualized End-of-Life Care Record Actually Make a Difference?
Gabriella E Swanepoel, Sophie Williams, Daniel Monnery
Die Pharmazie
|
September 12, 2003
Differences between USP and BP dissolution results for oxytetracycline capsules after accelerated stability testing
E Swanepoel, W Liebenberg, M M de Villiers
Die Pharmazie
|
March 19, 2003
Developing a discriminating dissolution test for three mebendazole polymorphs based on solubility differences
E Swanepoel, W Liebenberg, B Devarakonda, et al.
Journal of Chromatography. A
|
April 5, 1996
Fluorimetric method of analysis for D-norpseudoephedrine hydrochloride, glycine and L-glutamic acid by reversed-phase high-performance liquid chromatography
E Swanepoel, M M de Villiers, J L du Preez
Clinical Chemistry
|
June 1, 1977
Increased concentrations of serum free fatty acids falsely increase serum thyroxine as determined by competitive protein-binding
P R Pannall, E Swanepoel, J M Bennett, et al.
Drug Development and Industrial Pharmacy
|
October 12, 2000
Dissolution properties of piroxicam powders and capsules as a function of particle size and the agglomeration of powders
E Swanepoel, W Liebenberg, M M de Villiers, et al.
Drug Development and Industrial Pharmacy
|
October 13, 1999
The effect of polymorphism on powder compaction and dissolution properties of chemically equivalent oxytetracycline hydrochloride powders
W Liebenberg, M M de Villiers, D E Wurster, et al.
Page
of 2